4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-16-088703
Chief Executive Officer acquired 131,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cooper Laurence James Neil Chief Executive Officer | 2015-12-31 | Grant or award | +131,000 | 1,131,000 | D |
Loading xslF345X03/doc4.xml…